当前位置: X-MOL 学术Org. Process Res. Dev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Facile and Scalable Methodology for the Pyrrolo[2,1-f][1,2,4]triazine of Remdesivir
Organic Process Research & Development ( IF 3.1 ) Pub Date : 2022-01-07 , DOI: 10.1021/acs.oprd.1c00071
Sarabindu Roy 1 , Ajay Yadaw 1 , Subho Roy 1 , Gopal Sirasani 2 , Aravind Gangu 2 , Jack D Brown 2 , Joseph D Armstrong 2 , Rodger W Stringham 3 , B Frank Gupton 3 , Chris H Senanayake 2 , David R Snead 3
Affiliation  

Pyrrolo[2,1-f][1,2,4]triazine (1) is an important regulatory starting material in the production of the antiviral drug remdesivir. Compound 1 was produced through a newly developed synthetic methodology utilizing simple building blocks such as pyrrole, chloramine, and formamidine acetate by examining the mechanistic pathway for the process optimization exercise. Triazine 1 was obtained in 55% overall yield in a two-vessel-operated process. This work describes the safety of the process, impurity profiles and control, and efforts toward the scale-up of triazine for the preparation of kilogram quantity.

中文翻译:

Remdesivir 的 Pyrrolo[2,1-f][1,2,4]三嗪的简便且可扩展的方法

Pyrrolo[2,1- f ][1,2,4]triazine ( 1 ) 是生产抗病毒药物 remdesivir 的重要监管起始材料。化合物1是通过一种新开发的合成方法生产的,该方法利用简单的结构单元,如吡咯、氯胺和醋酸甲脒,通过检查工艺优化活动的机制途径。在双容器操作的过程中,三嗪1的总产率为 55%。这项工作描述了该工艺的安全性、杂质分布和控制,以及为按比例放大三嗪以制备千克量的努力。
更新日期:2022-01-21
down
wechat
bug